Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Kidswell Bio Corporation

4584
Current price
115 JPY +3.02 JPY (+2.68%)
Last closed 112 JPY
ISIN JP3386460004
Sector Healthcare
Industry Biotechnology
Exchange Tokyo Stock Exchange
Capitalization 4 619 688 858 JPY
Yield for 12 month -12.88 %
1Y
3Y
5Y
10Y
15Y
4584
21.11.2021 - 28.11.2021

Kidswell Bio Corporation develops pharmaceuticals for the treatment of rare and intractable diseases in Japan. Its pipeline products include GND-004 for the treatment of ophthalmic disease and oncology; GND-007 for the treatment of immunological disease; and antibodies for oncology. The company pipeline products also include GBS-001, GBS-004, and GBS-010 for oncology; GBS-005 for immunological diseases; GBS-007 and GBS-012 for ophthalmic disease; GBS-008 for infectious diseases; and GBS-011 for renal disease. In addition, its products also include GCT-101 for alveolar cleft; GCT-102 for congenital isolated hypoganglionosis; and other pipeline products for ophthalmologic diseases, cerebral palsy, peripheral nerve palsy, fracture, and spinal cord injury. The company was formerly known as Gene Techno Science Co.,Ltd. and changed its name to Kidswell Bio Corporation in July 2021. The company was incorporated in 2001 and is headquartered in Tokyo, Japan. Address: Kanayama Building, Tokyo, Japan, 104-0033

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

69 333.98 JPY

P/E ratio

Dividend Yield

Current Year

+2 436 073 093 JPY

Last Year

+2 781 764 743 JPY

Current Quarter

+483 918 019 JPY

Last Quarter

+866 213 385 JPY

Current Year

+1 041 451 309 JPY

Last Year

+1 528 723 090 JPY

Current Quarter

+224 069 997 JPY

Last Quarter

+176 800 095 JPY

Key Figures 4584

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -918 824 776 JPY
Operating Margin TTM -32.99 %
PE Ratio
Return On Assets TTM -15.45 %
PEG Ratio
Return On Equity TTM -17.95 %
Wall Street Target Price 69 333.98 JPY
Revenue TTM 1 880 612 923 JPY
Book Value 18.12 JPY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 948.3 %
Dividend Yield
Gross Profit TTM 1 020 025 811 JPY
Earnings per share -40.31 JPY
Diluted Eps TTM -40.31 JPY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 1211.3 %
Profit Margin -16.09 %

Dividend Analytics 4584

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 4584

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 2:1
Payout Ratio
Last Split Date 27.06.2018
Dividend Date

Stock Valuation 4584

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.0053
Price Sales TTM 2.4565
Enterprise Value EBITDA -4.6827
Price Book MRQ 5.4502

Financials 4584

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 4584

For 52 weeks

88.18 JPY 185.37 JPY
50 Day MA 120.16 JPY
Shares Short Prior Month
200 Day MA 132.8 JPY
Short Ratio
Shares Short
Short Percent